1-4 of 4
Wallace Y Langdon, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The FLT3 Inhibitor Quizartinib Provides a Novel Strategy to Inhibit Chemotherapy-Induced Myelosuppression

Wallace Y Langdon, PhD, Samuel J Taylor, PhD, Johanna M Duyvestyn, BSc(Hons), Samantha A Dagger, BSc(Hons), George S. Vassiliou, MD PhD, Carolyn s. Grove, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4041.
https://doi.org/10.1182/blood.V128.22.4041.4041
Published: 2016
Journal Articles

Control of JAK2 Ubiquitination and Stability By CBL Family E3 Ubiquitin Ligases in Hematopoietic Stem/Progenitor Cells and Myeloid Malignancies

Kaosheng Lyu, PhD, Jing Jiang, PhD, Wei An, PhD, Wallace Y Langdon, PhD, Hamid Band, MD PhD, Wei Tong, PhD
Journal: Blood
Blood (2016) 128 (22): 723.
https://doi.org/10.1182/blood.V128.22.723.723
Published: 2016
Journal Articles

FLT3 Inhibitor AC220 Is a Potent Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice

Wallace Y Langdon, PhD, Samantha A Dagger, Samuel J Taylor, Christine B F Thien, PhD, Matthew E Wikstrom, PhD
Journal: Blood
Blood (2011) 118 (21): 642.
https://doi.org/10.1182/blood.V118.21.642.642
Published: 2011
Journal Articles

Cbl-Deficient Mice Display Erythropoietin Hypersensitivity and Enhanced Phosphorylation of Protein Kinase B/Akt.

Terri D. Richmond, BSc, Monica L. Bailey, BSc, Wallace Y. Langdon, PhD, Dwayne L. Barber, PhD
Journal: Blood
Blood (2005) 106 (11): 3137.
https://doi.org/10.1182/blood.V106.11.3137.3137
Published: 2005